[Antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: 2022: Guidelines from the supportive care committee of the French Society of Childhood Cancer (SFCE)]. / Nausées-vomissements induits par les traitements anticancéreux (NVITAC) en onco-hématologie pédiatrique : recommandations 2022 du Comité soins de support de la SFCE.
Bull Cancer
; 109(11): 1144-1153, 2022 Nov.
Article
em Fr
| MEDLINE
| ID: mdl-36220696
ABSTRACT
Nausea and vomiting induced by cancer treatment (CINV) remain one of the most common and feared side effects in children despite the use of new drugs to prevent them. The existing recommendations for the prophylaxis and treatment of CINV are based on adult patients in Anglo-Saxon societies. Based on a recent review of the literature, we focused on specific pediatric issues in order to offer recommendations validated by the supportive care committee of the French society for childhood cancer.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
1_ASSA2030
/
2_ODS3
Base de dados:
MEDLINE
Assunto principal:
Hematologia
/
Antieméticos
/
Neoplasias
/
Antineoplásicos
Tipo de estudo:
Guideline
Limite:
Adult
/
Child
/
Humans
Idioma:
Fr
Revista:
Bull Cancer
Ano de publicação:
2022
Tipo de documento:
Article